Paper4201876
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
Altman RD and 5 others. N Engl J Med, 1973. Cited by 257 papers, by iCite.
Cite this record
ConductScience Library. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). Papers, record 4201876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4201876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Organophosphorus Compounds | Major topic |
| Osteitis Deformans | Major topic |
| Administration, Oral | |
| Aged | |
| Alkaline Phosphatase | |
| Bone and Bones | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Drug Evaluation | |
| Etidronic Acid | |
| Female | |
| Fluorides | |
| Humans | |
| Hydroxyproline | |
| Isotopes | |
| Male | |
| Middle Aged | |
| Pain | |
| Placebos | |
| Radiography | |
| Strontium Isotopes | |
| Time Factors |
Source PubMed
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 257 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37198232 | Targeting strategies for bone diseases: signaling pathways and clinical studies. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37198232 | PubMed |
| 36288714 | Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2. | Cell Rep | 2022 | https://conductscience.org/library/papers/36288714 | PubMed |
| 33312475 | Therapeutic Dimensions of Bisphosphonates: A Clinical Update. | Int J Prev Med | 2020 | https://conductscience.org/library/papers/33312475 | PubMed |
| 32115673 | Clinical features, diagnosis and treatment of Paget's disease of bone in mainland China: A systematic review. | Rev Endocr Metab Disord | 2020 | https://conductscience.org/library/papers/32115673 | PubMed |
| 31848640 | Management of Paget's disease of bone. | Osteoporos Int | 2020 | https://conductscience.org/library/papers/31848640 | PubMed |
| 30803025 | Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline. | J Bone Miner Res | 2019 | https://conductscience.org/library/papers/30803025 | PubMed |
| 29192423 | Bisphosphonates for Paget's disease of bone in adults. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29192423 | PubMed |
| 22223192 | A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery? | Ir J Med Sci | 2012 | https://conductscience.org/library/papers/22223192 | PubMed |
| 21847749 | Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies. | Skeletal Radiol | 2011 | https://conductscience.org/library/papers/21847749 | PubMed |
| 21437131 | Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials. | Diabetes Metab Syndr Obes | 2009 | https://conductscience.org/library/papers/21437131 | PubMed |
| 19946296 | Metabolic bone diseases: treating Paget disease: when matters more than how. | Nat Rev Rheumatol | 2009 | https://conductscience.org/library/papers/19946296 | PubMed |
| 16937267 | Guidelines for diagnosis and management of Paget's disease of bone in Japan. | J Bone Miner Metab | 2006 | https://conductscience.org/library/papers/16937267 | PubMed |
| 11298188 | Calcitonin and calcitonin receptors: bone and beyond. | Int J Exp Pathol | 2000 | https://conductscience.org/library/papers/11298188 | PubMed |
| 10780527 | Bisphosphonates induce apoptosis in human breast cancer cell lines. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10780527 | PubMed |
| 9820883 | Bisphosphonates in bone diseases. | Pharm World Sci | 1998 | https://conductscience.org/library/papers/9820883 | PubMed |
| 8894359 | The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease. | Clin Rheumatol | 1996 | https://conductscience.org/library/papers/8894359 | PubMed |
| 7521833 | Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. | Drugs | 1994 | https://conductscience.org/library/papers/7521833 | PubMed |
| 7506648 | Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. | Drugs | 1993 | https://conductscience.org/library/papers/7506648 | PubMed |
| 7426385 | The effects of calcitonin and colchicine on the cellular response to diphosphonate. | Br J Exp Pathol | 1980 | https://conductscience.org/library/papers/7426385 | PubMed |
| 7014170 | Pharmacology and therapeutic use of calcitonin. | Drugs | 1981 | https://conductscience.org/library/papers/7014170 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4201876
GET https://conductscience.org/api/papers/v1/4201876/cited_by?page=2